| Dr Varaz Bozoghlanian, MD | |
|
18372 Clark St Ste 208, Tarzana, CA 91356-3552 | |
| (818) 345-3929 | |
| (818) 345-4862 |
| Full Name | Dr Varaz Bozoghlanian |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 18372 Clark St Ste 208, Tarzana, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174751382 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | A115637 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy Asthma Care Center, Inc | 1658470133 | 4 |
News Archive
Gilead Sciences, Inc. today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 1 in support of approval of the Quad, a complete single tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, for the treatment of HIV-1 infection in treatment-naïve adults.
Researchers at the University of Southern California (USC) have identified a novel mechanism in the regulation and differentiation of neural stem cells.
Highly publicized vaccine products not only boost the bottom lines of pharmaceutical companies, but also benefit insurance companies, doctors and retailers with their businesses, according to analysis of the recent flu vaccine season by life science market research publisher Kalorama Information.
Is cancer an inevitable consequence of aging? Although it is widely thought that cancer is an inevitable consequence of aging, the risk of developing several common cancers decreases with age.
Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Cancer Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma.
› Verified 8 days ago
| Entity Name | Allergy Asthma Care Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891758751 PECOS PAC ID: 1658470133 Enrollment ID: O20070625000242 |
News Archive
Gilead Sciences, Inc. today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 1 in support of approval of the Quad, a complete single tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, for the treatment of HIV-1 infection in treatment-naïve adults.
Researchers at the University of Southern California (USC) have identified a novel mechanism in the regulation and differentiation of neural stem cells.
Highly publicized vaccine products not only boost the bottom lines of pharmaceutical companies, but also benefit insurance companies, doctors and retailers with their businesses, according to analysis of the recent flu vaccine season by life science market research publisher Kalorama Information.
Is cancer an inevitable consequence of aging? Although it is widely thought that cancer is an inevitable consequence of aging, the risk of developing several common cancers decreases with age.
Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Cancer Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Varaz Bozoghlanian, MD 11500 W Olympic Blvd, Ste 630, Los Angeles, CA 90064-1524 Ph: (310) 393-1550 | Dr Varaz Bozoghlanian, MD 18372 Clark St Ste 208, Tarzana, CA 91356-3552 Ph: (818) 345-3929 |
News Archive
Gilead Sciences, Inc. today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 1 in support of approval of the Quad, a complete single tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, for the treatment of HIV-1 infection in treatment-naïve adults.
Researchers at the University of Southern California (USC) have identified a novel mechanism in the regulation and differentiation of neural stem cells.
Highly publicized vaccine products not only boost the bottom lines of pharmaceutical companies, but also benefit insurance companies, doctors and retailers with their businesses, according to analysis of the recent flu vaccine season by life science market research publisher Kalorama Information.
Is cancer an inevitable consequence of aging? Although it is widely thought that cancer is an inevitable consequence of aging, the risk of developing several common cancers decreases with age.
Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Cancer Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma.
› Verified 8 days ago
Tania Kimia, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 19349 Rosita St, Tarzana, CA 91356 Phone: 818-807-6170 Fax: 323-584-0810 | |
Lawrence Strick, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 18372 Clark St, Ste 208, Tarzana, CA 91356 Phone: 818-345-3929 Fax: 818-345-4862 | |
Brian K Greenberg, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 18370 Burbank Blvd, Suite 307, Tarzana, CA 91356 Phone: 818-996-6000 Fax: 818-996-4712 | |
Dr. Glenn Joseph Lawlor Jr., MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 18372 Clark St Ste 208, Tarzana, CA 91356 Phone: 818-345-3929 Fax: 818-345-4862 |